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Introduction
The strychnine-sensitive glycine receptor (GlyR) is a member of cysteine loop family of ligand-gated ion channels (Connolly and Wafford, 2004) , which plays important roles in the spinal cord and brain stem (Betz and Laube, 2006; Lynch, 2004) . To date, four α subunits (α1, α2, α3, and α4) and one β subunit have been identified (Lynch, 2004) . During spinal cord development, there is a switch from α2 subunit to α1 subunit (Aguayo et al., 2004; Becker et al., 1988; Watanabe and Akagi, 1995) , suggesting a role of α2 subunit containing-GlyRs in neuronal development. This has been supported by two recent studies. First, activation of α2-GlyRs expressed in retinal progenitor cells regulates the number of rod photoreceptors in the developing retina (Young and Cepko, 2004) . Second, in the spinal cord, α2-GlyRs regulate interneuron differentiation and the locomotor circuitry in zebrafish (McDearmid et al., 2006) . In addition, various GlyR subunits exhibit uneven regional distributions in the adult central nervous system (CNS) (Malosio et al., 1991) . In forebrain neurons, glycine receptor is thought to be mainly homopentamer of α2 subunits that exert their function extrasynaptically (Brackmann et al., 2004) . This implies that, in addition to their significance in development, the variation of GlyRs permitted by the expression of multiple subunits adds MOL #42655 7 sucrose (3300, Norwood, MA, USA). Patch pipettes were pulled from glass capillaries with an outer diameter of 1.5 mm on a two-stage puller (PP-830, Narishige, Tokyo, Japan). The resistance of pipettes was 3-5 MΩ when filled with the patch pipette solution which contained (in mM): 120 KCl, 30 NaCl, 1 MgCl 2 , 0.5 CaCl 2 , 5 EGTA, 2 Mg-ATP, 10 HEPES, with the pH adjusted to 7.2 with Tris-base. When the I-V relationships for I Gly were examined, 300 nM tetrodotoxin (TTX) and 100 µ M CdCl 2 were added to the standard external solution and K + was replaced with Cs + in the pipette solution. Membrane currents were measured using a patch-clamp amplifier (Axon 200B, Axon Instruments, Foster City, CA, USA), filtered with a cut-off frequency of 2 kHz, sampled at a rate of 100 kHz and analyzed using a Digidata 1320A interface and a personal computer with Clampex and Clampfit software (Version 9.0.1, Axon Instruments). Unless otherwise noted, the membrane potential was held at -60 mV throughout the experiment. All the experiments were carried out at room temperature (22-25℃). The average access resistances for neurons and HEK293T cells used in the experiments are all about 10 MΩ. The average whole-cell capacitance for the hippocampal neurons, the spinal cord neurons and HEK293T cells is about 25, 20 and 30 pF, respectively.
Drugs.
All drugs were purchased from Sigma. Picrotoxin (PTX) and CTZ were initially dissolved as concentrated stocks solutions in dimethylsulphoxide (DMSO) and subsequently diluted to the desired concentration in standard external solution. The final DMSO concentration was lower than 0.1%. Other Drugs were first dissolved in ion-free water and then diluted to the final concentrations in the standard external solution just before use or dissolved directly in the standard external solution. Drugs were applied using a rapid application technique termed the "Y-tube" method throughout the experiments. This system allows a complete exchange of external solution surrounding a neuron within 20 ms (Murase et al., 1990) . Throughout the experiment the bath was superfused continuously with the standard external solution.
Data Analysis. The software Clampfit 9.0.1 (Axon Instruments, Forster City, CA, USA) was This article has not been copyedited and formatted. The final version may differ from this version. 
Where I is the normalized value of the current, I max is the maximal response, C is the drug concentration, EC 50 is the agonist concentration producing a half-maximal response and h is the apparent Hill coefficient. The curve for the effect of CTZ on I Gly was fitted by the following equation:
Where IC 50 represents the antagonist concentration producing a half-maximal inhibitory effect and the others are the same as described above. All data were calculated as the mean ± standard error (SEM). When quantification analysis was made, statistical comparison was carried out using Student's t test for the comparison of two groups. Statistically significant differences were assumed as P < 0.05 for all data. P and n represent the value of significance and the number of neurons, respectively.
0BResults
CTZ Effects on Cultured Rat Hippocampal Neurons. Glycine and taurine are the major endogenous ligands of GlyRs in mammalian CNS (Mori et al., 2002) , therefore we first examined the effects of CTZ on both glycine-and taurine-evoked currents (I Gly and I Tau , respectively) in cultured rat hippocampal neurons. At a holding potential (V H ) of -60 mV under the whole-cell voltage clamp mode, bath application of glycine (100 µM) and taurine (500 µM in the presence of 10 µM bicuculline for blocking GABA A receptor) evoked inward currents in all tested neurons under our experimental conditions (161 and 153 mM Cl -in the external and internal solutions, respectively) (Fig. 1A) . These currents were strychnine-sensitive (data not shown). Addition of CTZ (100 µM) resulted in a rapid reduction of the current amplitude (Fig. 1A, B wash-off. The concentration-dependence of CTZ inhibition was investigated with 30 µM and 100 µM glycine. Figure 1C shows that CTZ caused a concentration-dependent reduction of I Gly , the IC 50 value of CTZ for the current induced by 30 µM glycine is 22.2 ± 4.2 µM and significantly increased to 95.7 ± 2.0 µM for that induced by 100 µM glycine. This significant alteration of the CTZ concentration-response relationship by glycine concentration suggests the competitive interaction between glycine and CTZ.
To elucidate whether CTZ interferes with glycine binding to the GlyR, we recorded I Gly in the absence or presence of CTZ. We found that the inhibition of CTZ depended on glycine concentrations (Fig. 1D ). As shown in Fig. 1E , the EC 50 of I Gly without CTZ was 34.1 ± 6.5 Use-independence of CTZ Inhibition. The concentration-dependence of CTZ effect suggests a competitive manner of CTZ inhibition. We tested this hypothesis further by comparing the inhibition of I Gly with four different CTZ application protocols. As shown in Fig. 2A and B, pretreatment of CTZ followed by co-application of CTZ and glycine produced the most marked inhibition, although prolonged pretreatment of CTZ did not further the effect. However, the inhibition caused by the sequential application of CTZ and glycine ( CTZ interacts with GlyR before glycine application suggests that CTZ inhibition of I Gly is independent of channel opening, favoring the idea that CTZ competes with the agonist at the GlyR.
As shown in Fig. 2C , CTZ pulses rapidly reduced I Gly in the continuous presence of glycine, consistent with a direct interaction of CTZ with GlyRs, without involvement of any intracellular signaling pathways. This experiment also showed that repeated CTZ application inhibited I Gly to a similar extent, indicating that the inhibition is use-independent.
Additive Effect of Picrotoxin and CTZ. To make sure that CTZ really inhibits GlyRs independent of channel opening, we further examined the mutual effect of CTZ and CTZ Inhibition Is α2 Subunit-specific. Previous studies have shown that hippocampal neurons express multiple GlyR isoforms (Malosio et al., 1991) . To determine the subunit specificity of CTZ inhibition, we examined the CTZ effect in HEK293T cells expressing the α1, α2 and α3 subunits of the GlyR, either alone or together with the β subunit. The EC 50
and n H values for each of the 6 receptor subtypes are summarized in Table 1 . As shown in Fig. 4A, the currents activated by 100 µM glycine were recorded in HEK293T cells expressing This article has not been copyedited and formatted. The final version may differ from this version. different homomeric (α1, α2 or α3) and heteromeric (α1 β, α2 β or α3 β) GlyRs.
Furthermore, CTZ inhibited I Gly mediated by homomeric α2-and heteromeric α2β-GlyRs in a concentration-dependent manner (Fig. 4B) . In order to further compare the difference of CTZ modulation on α1, α2 and α3 GlyR, we test the effects of CTZ on I Gly induced by an equally efficacious concentration of glycine (EC 70 : 50 µM for α1-GlyR, 100 µM for α2-GlyR and 150 µM for α1-GlyR) in these homomeric GlyR. In contrast to α2-containing GlyRs, I Gly induced by EC 70 glycine concentration in α1-and α3-GlyRs were essentially unaffected by CTZ (Fig. 4C ). Co-expressing α and β subunits in HEK293T cells with an excess of β subunit leads to the near exclusive formation of functional αβ heteromers (Bormann et al., 1993; Pribilla et al., 1992) . The characteristic reduction in PTX sensitivity was used to test the successful incorporation of β subunit to functional receptors. The IC 50
value of PTX for homomeric α1, α2 and α3 GlyR was 8.2 ± 1.4, 3.6 ± 0.9 and 10.6 ± 1.9 µM, respectively. After incorporation of β subunit, the IC 50 value of PTX was increased to 232 ± 25, 38.3 ± 3.8 and 218 ± 32 µM, respectively. Thus, the significant reduction of PTX sensitivity confirmed that heteromeric GlyRs were functionally expressed in HEK293T cells.
We found that the CTZ sensitivity of α2β heteromers (IC 50 = 76 ± 37 µM, n=5-7) was indistinguishable from that of α2 homomers (IC 50 = 51 ± 21 µM, n=5-10).
Threonine at Position 59 Confers the Specificity of CTZ Inhibition on α2-GlyR. Based on the competitive nature of CTZ inhibition, we hypothesized that the binding site of CTZ was close to the glycine binding domain on GlyRs. By comparing the properties of the extracellular amino acid residues of three GlyR α subunits through sequence alignment, we found that the following residues T59, S78, D117, T160, L178, S179, G203 in the α2 subunit differ from the corresponding sites in α1 and α3 subunits. CTZ may bind to these residues and then produce competitive inhibition on α2-GlyRs. To explore which residues may be involved in the CTZ inhibition of α2-GlyRs, the effect of CTZ on I Gly mediated by various mutated forms of homomeric α2-GlyRs with amino acid replacement (T59A, S78P, D117A, T160I, L178Q, S179D or G203R) was examined. The EC 50 and n H values for each of the mutants are summarized in Table 1 . We compared the percent inhibition of CTZ on I Gly in This article has not been copyedited and formatted. The final version may differ from this version. HEK293T cells expressing wide type (WT) α2-and those carrying α2-GlyR mutants. As shown in Fig. 5C , the glycine EC 50 value for WT α2-GlyR was 60.1 ± 3.4 µM, and it was decreased to 48.1 ± 2.5 µM by the T59A mutation, suggesting enhanced glycine sensitivity.
The glycine EC 70 value for WT α2-GlyR is 100 µM which we mainly used for activating GlyR in other experiments. While the equally efficacious concentration for mutant α2
(T59A)-GlyR is 80 µM. With this equally efficacious concentration, we compared the CTZ effects on I Gly mediated by WT α2-GlyR and α2 (T59A) mutant. We found that in cells expressing the mutant α2 (T59A) subunit, the percent inhibition of I Gly was significantly reduced (Fig. 5D) . The threshold concentration for statistically significant CTZ inhibition was 10 µM for WT α2-GlyR and 300 µM for the mutated α2-GlyRs (T59A), respectively.
Due to the limited solubility of CTZ, no concentration of CTZ greater than 300 µM was used in this study. The percent inhibition of CTZ (100 µM) on the current induced by 100 µM glycine in α2-GlyR with single mutation of S78P, D117A, T160I, G203R was 35.6 ± 5.3 %, 32.7 ± 4.8 %, 42.1 ± 6.3 % and 43.6 ± 7.2 %, respectively. Therefore, the effects of CTZ inhibition were not significantly affected by single mutations of S78P, D117A, T160I, G203R.
Because no functional GlyR was obtained by the double mutation of L178Q and S179D, the effects of L178 and S179 on CTZ inhibition of GlyR were not examined. Therefore, these data indicate that T59 at the N-terminal of α2 subunit is critical for the specific inhibition of α2-GlyRs by CTZ.
To establish that T59 residue specifically contributes to the CTZ inhibition of α2-GlyRs, we further performed reversal mutation in two insensitive subunits (α1 and α3) to see whether they can impart sensitivity to CTZ. Mutant homomeric α1 (A52T) and α3 (A52T)
GlyRs, corresponding to position of T59 in α2 subunit respectively (Fig. 5A) , were examined.
Interestingly, CTZ (100 µM) significantly inhibited I Gly induced by 100 µM glycine in HEK293T cells expressing mutated form of α1 (A52T) and α3 (A52T) GlyRs (Fig. 5E ).
Taken together, we conclude that T59 at the N-terminal of α2 subunit confers the specific inhibition of α2-GlyRs by CTZ.
.
CTZ Inhibition is Developmentally Regulated in Spinal Cord. A developmental switch
This article has not been copyedited and formatted. The final version may differ from this version. from α2 homomers to α1β heteromers has been reported for spinal GlyRs (Becker et al., 1988) . This differential expression pattern promotes us to examine whether CTZ inhibition of I Gly declined with time in cultured spinal neurons. As shown in Fig. 6 , CTZ markedly inhibited I Gly in neurons 5-7 days in vitro (DIV), whereas in neuron of DIV 12-14 and DIV 19-21, the inhibition became largely attenuated. Consistent with the predominant expression of α2 subunit in the hippocampus throughout the developmental stage, no significant difference about CTZ inhibition was observed in cultured hippocampal neurons during development. This specific decline of CTZ inhibition on I Gly in cultured spinal neurons further supports the notion that the CTZ action is α2 subunit specific.
Discussion
The main finding of this study is that CTZ, an epilepigenic agent that interacts with both The mutation of A52S in α1 subunit was shown to decrease glycine sensitivity on GlyRs (Saul et al., 1994) . In contrast, our results indicate the mutation of T59A, the corresponding site in α2 subunit only slightly altered the glycine sensitivity. However, T59A mutation largely eliminated the inhibitory effect of CTZ on α2-GlyR. Therefore, threonine in position This article has not been copyedited and formatted. The final version may differ from this version. GlyRs containing α1 or α3 subunits when the site corresponding to T59 of α2 subunit was changed to theronine (A52T). These data support the idea that a single amino acid at the extracelluar N-terminal can dramatically affect the regulatory properties of GlyRs (Mascia et al., 1996) .
Through site-directed mutagenesis combined with homology modeling based on the crystal structure of the acetylcholine binding protein, the ligand binding residues of α1 GlyR were investigated by previous studies (Grudzinska et al., 2005; Lynch, 2004) . A52 of α1 subunit is not one of the binding sites which were identified through homology modeling.
Thus T59 in α2 subunit, the corresponding residue of A52 in α1 subunit, may also not be the binding sites for glycine binding sites. However, A52 is one of the closest residues to the putative glycine binding sites as revealed by homology modeling (Speranskiy et al., 2007) . In addition, the mutation of A52S in α1 subunit was shown to decrease glycine sensitivity of GlyRs (Saul et al., 1994) . These studies suggest that A52 in α1 GlyR is relevant to the glycine binding site. Accordingly, T59 in α2 subunit, the corresponding residue of A52 in α1 subunit, may play a similar role in glycine binding through which CTZ exerts the competitive inhibition of GlyRs.
Previous studies have indicated that the expression of GlyR subunits in rat spinal cord neurons in vivo was developmentally regulated (Malosio et al., 1991; Watanabe and Akagi, 1995) . The α1 and β subunits are expressed at very low levels in embryonic rat spinal cord, with increasing expression during the first 2 postnatal weeks and the sustained high level thereafter. The α3 subunit is expressed after the third postnatal week and only at a low level.
In contrast, α2 expression is high and widespread in the embryonic nervous system and decreases gradually after birth. Similar developmental regulation of GlyR subunits expression has also been observed in primary cultures of spinal cord neurons -mRNA for α1 increased by 1.5-2 fold while that for α2 decreased substantially over the first 10 days in culture (Bechade et al., 1996) . Consistent with the selective inhibition of CTZ on α2-GlyRs expressed in HEK293T cells, we found that CTZ significantly inhibited I Gly in DIV 5-7 spinal This article has not been copyedited and formatted. The final version may differ from this version. dorsal horn neurons, but the inhibition was greatly reduced after DIV 12. These results show that CTZ inhibition of GlyRs in spinal cord is developmentally regulated, reflecting the α2-to-α1 switch of GlyR subunit (Aguayo et al., 2004; Bechade et al., 1996) , and support the notion of α2 subunit specificity of the CTZ action.
Unlike the high level of GlyR α1 subunit expression in the mature spinal cord, the α2-rather than α1-containing GlyR is the predominant form in the hippocampus (Malosio et al., 1991; Thio et al., 2003) . The physiological consequences of this distinct distribution pattern are difficult to establish because of the lack of specific antagonists. Thus CTZ may be a useful tool to study the molecular organization and function of GlyRs in the hippocampus.
Furthermore, recent studies have shown that the activation of α2-GlyRs is excitatory in developing cortex (Flint et al., 1998; Sturman, 1993) Therefore, the acute pharmacological inhibition of α2-GlyRs by CTZ may be helpful for studying the role of α2-GlyRs in neuronal development.
The endogenous amino acids, glycine, taurine and β-alanine, mediate tonic activation of α2-GlyRs, which maintains inhibitory tone in the hippocampus (Mori et al., 2002) . Moreover, the synaptic transmission in the rat hippocampus was also shown to be depressed by activation of GlyRs (Chattipakorn and McMahon, 2003; Song et al., 2006 Qi et al., 2006) . Because α2-GlyRs may promote interneuron development (McDearmid et al., 2006) , it is possible that the long-lasting effect of CTZ on overall network output in developing neural network may result from the impairment of interneuron differentiation due to its inhibition of α2-GlyRs. In addition, previous studies also indicated that GlyR α2 subunit mRNA as well as functional GlyRs are expressed in other forebrain areas, such as hypothalamus, dorsal striatum and amygdala (McCool and Farroni, 2001; Sergeeva and Haas, 2001) . Therefore, CTZ may also modulate neuronal excitability through inhibiting GlyR in these forebrain regions.
Both inhibitory glycine and GABA A receptors belong to the cysteine loop superfamily of ligand-gated ion channels. The homology between these two receptors may account for the similar inhibitory effect of CTZ. Unraveling the molecular mechanisms underlying the CTZ action on both glycine and GABA A receptors may yield critical insight into the specificity and mechanism of drug-receptor interactions.
Footnotes:
This study was supported by the National Natural Science Foundation of China (30621062) This article has not been copyedited and formatted. The final version may differ from this version. 
